Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

PIP

Pharmathene, (delisted) (PIP)

Pharmathene, (delisted)
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:PIP
DateHeureSourceTitreSymboleSociété
01/09/201714h49Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PIPPharmathene, (delisted)
01/09/201714h47Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PIPPharmathene, (delisted)
28/08/201722h57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PIPPharmathene, (delisted)
23/08/201722h29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:PIPPharmathene, (delisted)
22/08/201722h50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:PIPPharmathene, (delisted)
21/08/201723h02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:PIPPharmathene, (delisted)
21/08/201722h10Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PIPPharmathene, (delisted)
18/08/201723h18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:PIPPharmathene, (delisted)
14/08/201712h08Edgar (US Regulatory)Quarterly Report (10-q)AMEX:PIPPharmathene, (delisted)
10/08/201715h59Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)AMEX:PIPPharmathene, (delisted)
20/07/201723h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:PIPPharmathene, (delisted)
15/05/201723h22Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:PIPPharmathene, (delisted)
15/05/201723h17Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:PIPPharmathene, (delisted)
15/05/201723h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:PIPPharmathene, (delisted)
10/05/201722h13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:PIPPharmathene, (delisted)
05/05/201719h48Edgar (US Regulatory)(25)AMEX:PIPPharmathene, (delisted)
04/05/201723h18Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:PIPPharmathene, (delisted)
03/05/201722h57Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:PIPPharmathene, (delisted)
03/05/201722h30PR Newswire (US)PharmAthene Reports First Quarter 2017 Financial and Operational ResultsAMEX:PIPPharmathene, (delisted)
07/04/201712h01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:PIPPharmathene, (delisted)
03/04/201722h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:PIPPharmathene, (delisted)
31/03/201720h41Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:PIPPharmathene, (delisted)
14/03/201721h45Edgar (US Regulatory)Annual Report (10-k)AMEX:PIPPharmathene, (delisted)
14/03/201721h03PR Newswire (US)PharmAthene Reports Year-End 2016 Financial and Operational ResultsAMEX:PIPPharmathene, (delisted)
13/03/201713h03PR Newswire (US)PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction ...AMEX:PIPPharmathene, (delisted)
08/02/201714h29InvestorsHub NewsWirePPMH Wholly-Owned Subsidiary, mPath Discovery LLC, Expands Client Base with Multiple New Channel Partnership AgreementsAMEX:PIPPharmathene, (delisted)
06/02/201712h33PR Newswire (US)Altimmune to Present at the BIO CEO & Investor ConferenceAMEX:PIPPharmathene, (delisted)
03/02/201723h27Edgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:PIPPharmathene, (delisted)
19/01/201712h30PR Newswire (US)PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious DiseasesAMEX:PIPPharmathene, (delisted)
22/11/201623h08Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:PIPPharmathene, (delisted)
 Showing the most relevant articles for your search:AMEX:PIP